Standards of care for Duchenne muscular dystrophy: brief TREAT-NMD recommendations.

@article{Sejerson2009StandardsOC,
  title={Standards of care for Duchenne muscular dystrophy: brief TREAT-NMD recommendations.},
  author={Thomas Sejerson and Kate M.D. Bushby},
  journal={Advances in experimental medicine and biology},
  year={2009},
  volume={652},
  pages={
          13-21
        }
}
Care for patients with Duchenne muscular dystrophy (DMD) is poorly standardised. There are many interventions in different systems which are known to improve outcomes in DMD but these are not uniformly applied. This leads to inequality in access to treatment, as well as problems for planning controlled trials of future therapeutics. A worldwide effort is underway to generate care guidelines for DMD, which involves the Centre for Disease Control in the USA and the TREAT-NMD network of excellence… 
The TREAT‐NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia
TLDR
How the TREAT‐NMD national patient registries for DMD were established and how successful they have been at fostering collaboration between academia, patient organizations, and industry are described are described.
Development of a Duchenne Muscular Dystrophy registry for children in South Africa to optimize care
TLDR
Understanding disease expression in a population is essential to focus targeted interventions, such as corticosteroids, to ensure they are safe and effective in the local setting and by maintaining a DMD specific disease registry this information can be attained.
Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database
TLDR
The data confirm the benefits of corticosteroid treatment on ambulation, need for scoliosis surgery, ventilation and, to a lesser extent, cardiomyopathy.
Muscular dystrophy: new challenges and review of the current clinical trials
TLDR
The advances in the field of muscular dystrophy have resulted in improved clinical course and survival, and the encouraging results of early experimental studies could further improve these outcomes in the future.
Long-term ventilation of patients with Duchenne muscular dystrophy: experiences at the Neuromuscular Centre Ulm
TLDR
The historic development of respiratory care at the Ulm Neuromuscular Centre is described, which describes the provision of assisted ventilation in DMD patients and the stigma hitherto attached to it as being merely a means of keeping a patient comfortable towards the end of life has now been dispelled.
Recent developments in Duchenne muscular dystrophy: facts and numbers
TLDR
Over the last decades, the identification of the dystrophin gene has led to a deeper understanding of the muscle cell membrane and the proteins responsible for membrane stability, which has strongly contributed to enhance knowledge on disease progression, underlying pathology and therapeutic development.
Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy
  • W. Liew, P. Kang
  • Medicine, Psychology
    Therapeutic advances in neurological disorders
  • 2013
TLDR
This work has shown that utilizing a probabilistic approach to treatment of Duchenne muscular dystrophy and spinal muscular atrophy is a viable option for both quality of life and life expectancy for affected individuals.
Workshop report Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy
TLDR
A workshop to discuss issues such as natural history, outcome measures, efficacy measurements, animal models and clinical study design as part of the coordinated response to the public consultation by the EMA on the draft guidelines for clinical investigation of medicinal products in Duchenne and Becker muscular dystrophy (DMD/BMD).
...
1
2
3
4
...

References

SHOWING 1-10 OF 11 REFERENCES
The role of corticosteroids in muscular dystrophy: A critical appraisal
TLDR
The therapeutic value of corticosteroid drugs in Duchenne muscular dystrophy is limited, but these drugs represent the best treatment option currently available.
Cardiovascular Health Supervision for Individuals Affected by Duchenne or Becker Muscular Dystrophy
TLDR
Recommendations for optimal cardiovascular evaluation are provided to health care specialists caring for individuals in whom the diagnosis of Duchenne or Becker muscular dystrophy has been confirmed.
Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement.
TLDR
This work presents a meta-analysis of consensus committee methodologies for Synthesizing Expert Consensus Evaluation and Anticipatory Guidance of the Patient with DMD onoutine Evaluation of Respiratory Function and End of Life Directives.
American Thoracic Society consensus conference (Finder JD, chair) Respiratory care of the patient with Duchenne muscular dystrophy
  • Am J Crit Care Med
  • 2004
Report of a Muscular Dystrophy
  • Camapign funded workshop Birmingham, UK, January
  • 2004
Report of a Muscular Dystrophy Camapign funded workshop Birmingham, UK Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention
  • Neuromuscular Disorders
  • 2004
...
1
2
...